Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity: 1968-1973, 1977-1993 and 1997-2003

Virology

Volumn 397, Issue 2, 2010, Pages 322-330

  Okada, Jun ^a,d   Ohshima, Nobuko ^a   Kubota Koketsu, Ritsuko ^c   Ota, Sayuri ^a   Takase, Wakana ^a   Azuma, Masachika ^d   Iba, Yoshitaka ^a   Nakagawa, Naoko ^e   Yoshikawa, Tetsushi ^b   Nakajima, Youichi ^b   Ishikawa, Toyokazu ^f   Asano, Yoshizo ^b   Okuno, Yoshinobu ^c,f   Kurosawa, Yoshikazu ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^d Institute for Antibodies Ltd   (Japan)

^e KOBE INSTITUTE OF HEALTH   (Japan)

^f Osaka University   (Japan)

Author keywords

Apheresis; Epidemics; Hemagglutinin; Influenza virus; Neutralizing antibody; Phage display Ab library

Indexed keywords

HEMAGGLUTININ; MONOCLONAL ANTIBODY; VIRUS PROTEIN;

ANTIBODY ISOLATION; ANTIBODY LIBRARY; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLUENZA VIRUS A H3N2; LEUKAPHERESIS; LYMPHOCYTE CLONE; NONHUMAN; PEDIATRICIAN; PHAGE DISPLAY; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS NEUTRALIZATION; VIRUS STRAIN; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; MALE; MIDDLE AGED; NEUTRALIZATION TESTS;

ORTHOMYXOVIRIDAE;

EID: 75749120153     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.11.025     Document Type: Article

References (19)

1. Bebbington C.R., Renner G., Thomson S., King D., Abrams D., and Yarranton G.T. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Bio/Technology 10 (1992) 169-175
2. Epstein S.L., Misplon J.A., Lawson C.M., Subbarao E.K., Connors M., and Murphy B.R. β2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J. Immunol. 150 (1993) 5484-5493
3. Fouchier R.A.M., Munster V., Wallensten A., Bestebroer T.M., Herfst S., Smith D., Rimmelzwaan G.F., Olsen B., and Osterhaus A.D.M.E. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79 (2005) 2814-2822
4. Gerhard W., Mozdzanowska K., Furchner M., Washko G., and Maiese K. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immuno. Rev. 159 (1997) 95-103
5. Gherardi E., and Milstein C. Original and artificial antibodies. Nature 357 (1992) 201-202
6. Hay A.J., Gregory V., Douglas A.R., and Lin Y.P. The evolution of human influenza viruses. Phil. Trans. Soc. Lond. B 356 (2001) 1861-1870
7. Iba Y., Ito W., and Kurosawa Y. Expression vectors for the introduction of highly diverged sequences into the six complementarity-determining regions of an antibody. Gene 194 (1997) 35-46
8. Ito W., and Kurosawa Y. Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of protein A. J. Biol. Chem. 268 (1993) 20668-20675
9. Marks J.D., Hoogenboom H.R., Bonnert T.P., McCafferty J., Griffiths A.D., and Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222 (1991) 581-597
10. Morino K., Katsumi H., Akahori Y., Iba Y., Shinohara M., Ukai Y., Kohara Y., and Kurosawa Y. Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression. J. Immunol. Meth. 257 (2001) 175-184
11. Nakagawa N., Kubota R., Nakagawa T., and Okuno Y. Antigenic variants with amino acid deletions clarify a neutralizing epitope specific for influenza B virus Victoria group strains. J. Gen. Virol. 82 (2001) 2169-2172
12. Nakagawa N., Kubota R., Nakagawa T., and Okuno Y. Neutralizing epitopes specific for influenza B virus Yamagata group strains are in the 'loop'. J. Gen. Virol. 84 (2003) 769-773
13. Palese P. Influenza: old and new threats. Nat. Med. 10 (2004) S82-S87
14. Palladino G., Mozdzanowska K., Washko G., and Gerhard W. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol. 69 (1995) 2075-2081
15. Underwood P.A. Mapping of antigenic changes in the haemagglutinin of Hong Kong influenza (H3N2) strains using a large panel of monoclonal antibodies. J. Gen. Virol. 62 (1982) 153-169
16. Vanlandschoot P., Beirnaert E., Dewilde S., Saelens X., Bestebroer T., De Jong J., Jou W.M., and Fiers W. A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody. Virology 212 (1995) 526-534
17. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., and Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56 (1992) 152-179
18. Wiley D.C., Wilson I.A., and Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289 (1981) 373-378
19. Winter G., Griffiths A.D., Hawkins R.E., and Hoogenboom H.R. Making antibodies by phage display technology. Annu. Rev. Immunol. 12 (1994) 433-455